Cargando…
Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study
INTRODUCTION: Shielding aimed to protect those predicted to be at highest risk from COVID-19 and was uniquely implemented in the UK during the first year of the pandemic from March 2020. As the first stage in the EVITE Immunity evaluation (Effects of shielding for vulnerable people during COVID-19 p...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407356/ https://www.ncbi.nlm.nih.gov/pubmed/37541747 http://dx.doi.org/10.1136/bmjopen-2023-073464 |
_version_ | 1785085943135338496 |
---|---|
author | Porter, Alison Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Dixon, Lucy Edwards, Adrian Evans, Bridie Griffiths, Lesley John, Ann Jolles, Stephen Kingston, Mark Rhys Lyons, Ronan Morgan, Jennifer Sewell, Bernadette Whiffen, Anthony Williams, Victoria Angharad Snooks, Helen |
author_facet | Porter, Alison Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Dixon, Lucy Edwards, Adrian Evans, Bridie Griffiths, Lesley John, Ann Jolles, Stephen Kingston, Mark Rhys Lyons, Ronan Morgan, Jennifer Sewell, Bernadette Whiffen, Anthony Williams, Victoria Angharad Snooks, Helen |
author_sort | Porter, Alison |
collection | PubMed |
description | INTRODUCTION: Shielding aimed to protect those predicted to be at highest risk from COVID-19 and was uniquely implemented in the UK during the first year of the pandemic from March 2020. As the first stage in the EVITE Immunity evaluation (Effects of shielding for vulnerable people during COVID-19 pandemic on health outcomes, costs and immunity, including those with cancer:quasi-experimental evaluation), we generated a logic model to describe the programme theory underlying the shielding intervention. DESIGN AND PARTICIPANTS: We reviewed published documentation on shielding to develop an initial draft of the logic model. We then discussed this draft during interviews with 13 key stakeholders involved in putting shielding into effect in Wales and England. Interviews were recorded, transcribed and analysed thematically to inform a final draft of the logic model. RESULTS: The shielding intervention was a complex one, introduced at pace by multiple agencies working together. We identified three core components: agreement on clinical criteria; development of the list of people appropriate for shielding; and communication of shielding advice. In addition, there was a support programme, available as required to shielding people, including food parcels, financial support and social support. The predicted mechanism of change was that people would isolate themselves and so avoid infection, with the primary intended outcome being reduction in mortality in the shielding group. Unintended impacts included negative impact on mental and physical health and well-being. Details of the intervention varied slightly across the home nations of the UK and were subject to minor revisions during the time the intervention was in place. CONCLUSIONS: Shielding was a largely untested strategy, aiming to mitigate risk by placing a responsibility on individuals to protect themselves. The model of its rationale, components and outcomes (intended and unintended) will inform evaluation of the impact of shielding and help us to understand its effect and limitations. |
format | Online Article Text |
id | pubmed-10407356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-104073562023-08-09 Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study Porter, Alison Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Dixon, Lucy Edwards, Adrian Evans, Bridie Griffiths, Lesley John, Ann Jolles, Stephen Kingston, Mark Rhys Lyons, Ronan Morgan, Jennifer Sewell, Bernadette Whiffen, Anthony Williams, Victoria Angharad Snooks, Helen BMJ Open Public Health INTRODUCTION: Shielding aimed to protect those predicted to be at highest risk from COVID-19 and was uniquely implemented in the UK during the first year of the pandemic from March 2020. As the first stage in the EVITE Immunity evaluation (Effects of shielding for vulnerable people during COVID-19 pandemic on health outcomes, costs and immunity, including those with cancer:quasi-experimental evaluation), we generated a logic model to describe the programme theory underlying the shielding intervention. DESIGN AND PARTICIPANTS: We reviewed published documentation on shielding to develop an initial draft of the logic model. We then discussed this draft during interviews with 13 key stakeholders involved in putting shielding into effect in Wales and England. Interviews were recorded, transcribed and analysed thematically to inform a final draft of the logic model. RESULTS: The shielding intervention was a complex one, introduced at pace by multiple agencies working together. We identified three core components: agreement on clinical criteria; development of the list of people appropriate for shielding; and communication of shielding advice. In addition, there was a support programme, available as required to shielding people, including food parcels, financial support and social support. The predicted mechanism of change was that people would isolate themselves and so avoid infection, with the primary intended outcome being reduction in mortality in the shielding group. Unintended impacts included negative impact on mental and physical health and well-being. Details of the intervention varied slightly across the home nations of the UK and were subject to minor revisions during the time the intervention was in place. CONCLUSIONS: Shielding was a largely untested strategy, aiming to mitigate risk by placing a responsibility on individuals to protect themselves. The model of its rationale, components and outcomes (intended and unintended) will inform evaluation of the impact of shielding and help us to understand its effect and limitations. BMJ Publishing Group 2023-08-04 /pmc/articles/PMC10407356/ /pubmed/37541747 http://dx.doi.org/10.1136/bmjopen-2023-073464 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Public Health Porter, Alison Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Dixon, Lucy Edwards, Adrian Evans, Bridie Griffiths, Lesley John, Ann Jolles, Stephen Kingston, Mark Rhys Lyons, Ronan Morgan, Jennifer Sewell, Bernadette Whiffen, Anthony Williams, Victoria Angharad Snooks, Helen Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study |
title | Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study |
title_full | Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study |
title_fullStr | Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study |
title_full_unstemmed | Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study |
title_short | Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study |
title_sort | rationale for the shielding policy for clinically vulnerable people in the uk during the covid-19 pandemic: a qualitative study |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407356/ https://www.ncbi.nlm.nih.gov/pubmed/37541747 http://dx.doi.org/10.1136/bmjopen-2023-073464 |
work_keys_str_mv | AT porteralison rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT akbariashley rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT carsonstevensandrew rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT dalejeremy rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT dixonlucy rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT edwardsadrian rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT evansbridie rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT griffithslesley rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT johnann rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT jollesstephen rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT kingstonmarkrhys rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT lyonsronan rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT morganjennifer rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT sewellbernadette rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT whiffenanthony rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT williamsvictoriaangharad rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy AT snookshelen rationalefortheshieldingpolicyforclinicallyvulnerablepeopleintheukduringthecovid19pandemicaqualitativestudy |